Inhibitory effect of Lactobacillus acidophilus on Helicobacter hepaticus in vitro

World Journal of Microbiology and Biotechnology

Volumn 29, Issue 3, 2013, Pages 499-504

  Zhang, Manhua ^a,b   Zhang, Haiyang ^c   Li, Yan ^b   Qi, Wenqian ^b   Wang, Xu ^b   Wang, Jiangbin ^b  

^a Shenzhen Prevention and Treatment Center for Occupational Diseases   (China)

^b CHINA JAPAN UNION HOSPITAL OF JILIN UNIVERSITY   (China)

^c JILIN UNIVERSITY   (China)

Author keywords

H. hepaticus; H. pylori; Inhibitory effect; Lactobacillus acidophilus; Urease activity

Indexed keywords

BACILLI; CELL PROLIFERATION; STRAIN;

H. HEPATICUS; H. PYLORI; INHIBITORY EFFECT; LACTOBACILLUS ACIDOPHILUS; UREASE ACTIVITY;

LACTIC ACID;

HELICOBACTER; HELICOBACTER HEPATICUS; HELICOBACTER PYLORI; LACTOBACILLUS ACIDOPHILUS;

EID: 84873566395     PISSN: 09593993     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11274-012-1203-2     Document Type: Article

References (37)

1. Avenaud P, Marais A, Monteiro L, Le Bail B, Bioulac Sage P, Balabaud C, Megraud F (2000) Detection of Helicobacter species in the liver of patients with and without primary liver carcinoma. Cancer 89(7): 1431-1439.
2. Bernet MF, Brassart D, Neeser JR, Servin AL (1994) Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut 35(4): 483-489.
3. Bhatia SJ, Kochar N, Abraham P, Nair NG, Mehta AP (1989) Lactobacillus acidophilus inhibits growth of Campylobacter pylori in vitro. J Clin Microbiol 27(10): 2328-2330.
4. Buchanan RE, Gibbons NE (1974) Bergey's manual of determinative bacteriology, 8th edn. The Williams and Wilkins Co., Balitmore.
5. Canella KA, Diwan BA, Gorelick PL, Donovan PJ, Sipowicz MA, Kasprzak KS, Weghorst CM, Snyderwine EG, Davis CD, Keefer LK, Kyrtopoulos SA, Hecht SS, Wang M, Anderson LM, Rice JM (1996) Liver tumorigenesis by Helicobacter hepaticus: considerations of mechanism. In Vivo 10(3): 285-292.
6. Chen X, Fruehauf J, Goldsmith JD, Xu H, Katchar KK, Koon HW, Zhao D, Kokkotou EG, Pothoulakis C, Kelly CP (2009) Saccharomyces boulardii inhibits EGF receptor signaling and intestinal tumor growth in Apc (min) mice. Gastroenterology 137(3): 914-923.
7. Coconnier MH, Lievin V, Hemery E, Servin AL (1998) Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl Environ Microbiol 64(11): 4573-4580.
8. Eidt S, Stolte M (1995) The significance of Helicobacter pylori in relation to gastric cancer and lymphoma. Eur J Gastroenterol Hepatol 7(4): 318-321.
9. Elmer GW, Surawicz CM, McFarland LV (1996) Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections. JAMA 275(11): 870-876.
10. Foltz CJ, Fox JG, Cahill R, Murphy JC, Yan L, Shames B, Schauer DB (1998) Spontaneous inflammatory bowel disease in multiple mutant mouse lines: association with colonization by Helicobacter hepaticus. Helicobacter 3(2): 69-78.
11. Forman D (1996) Helicobacter pylori and gastric cancer. Scand J Gastroenterol Suppl 215: 48-51.
12. Fox JG, Dewhirst FE, Tully JG, Paster BJ, Yan L, Taylor NS, Collins MJ Jr, Gorelick PL, Ward JM (1994) Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice. J Clin Microbiol 32(5): 1238-1245.
13. Fox JG, Yan L, Shames B, Campbell J, Murphy JC, Li X (1996) Persistent hepatitis and enterocolitis in germfree mice infected with Helicobacter hepaticus. Infect Immun 64(9): 3673-3681.
14. Gill HS, Guarner F (2004) Probiotics and human health: a clinical perspective. Postgrad Med J 80(947): 516-526.
15. Herrera AG (2004) Helicobacter pylori and food products: a public health problem. Methods Mol Biol 268: 297-301.
16. Ji SW, Wang S, Wang JB, Zhang YG (2010) Investigation of Helicobacter hepaticus infection in various species of mice in China. Chin J Dig 30(9): 597-601.
17. Kabir AM, Aiba Y, Takagi A, Kamiya S, Miwa T, Koga Y (1997) Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model. Gut 41(1): 49-55.
18. Konstantinov SR, Awati AA, Williams BA, Miller BG, Jones P, Stokes CR, Akkermans AD, Smidt H, de Vos WM (2006) Post-natal development of the porcine microbiota composition and activities. Environ Microbiol 8(7): 1191-1199.
19. Lesbros-Pantoflickova D, Corthesy-Theulaz I, Blum AL (2007) Helicobacter pylori and probiotics. J Nutr 137(3 Suppl 2): 812S-818S.
20. Lorca GL, Wadstrom T, Valdez GF, Ljungh A (2001) Lactobacillus acidophilus autolysins inhibit Helicobacter pylori in vitro. Curr Microbiol 42(1): 39-44.
21. Luo YQ, Teng JB, Pan BR, Zhang XY (1999) Liver disease and Helicobacter. World J Gastroenterol 5(4): 334-338.
22. Michetti P, Dorta G, Wiesel PH, Brassart D, Verdu E, Herranz M, Felley C, Porta N, Rouvet M, Blum AL, Corthesy-Theulaz I (1999) Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans. Digestion 60(3): 203-209.
23. Midolo PD, Lambert JR, Hull R, Luo F, Grayson ML (1995) In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria. J Appl Bacteriol 79(4): 475-479.
24. Nilsson I, Lindgren S, Eriksson S, Wadstrom T (2000) Serum antibodies to Helicobacter hepaticus and Helicobacter pylori in patients with chronic liver disease. Gut 46(3): 410-414.
25. Nilsson HO, Mulchandani R, Tranberg KG, Stenram U, Wadstrom T (2001) Helicobacter species identified in liver from patients with cholangiocarcinoma and hepatocellular carcinoma. Gastroenterology 120(1): 323-324.
26. Parsonnet J (1995) Bacterial infection as a cause of cancer. Environ Health Perspect 103(Suppl 8): 263-268.
27. Ponzetto A, Pellicano R, Leone N, Cutufia MA, Turrini F, Grigioni WF, D'Errico A, Mortimer P, Rizzetto M, Silengo L (2000) Helicobacter infection and cirrhosis in hepatitis C virus carriage: is it an innocent bystander or a troublemaker? Med Hypotheses 54(2): 275-277.
28. Rice JM (1995) Helicobacter hepaticus, a recently recognized bacterial pathogen, associated with chronic hepatitis and hepatocellular neoplasia in laboratory mice. Emerg Infect Dis 1(4): 129-131.
29. Rolfe RD (2000) The role of probiotic cultures in the control of gastrointestinal health. J Nutr 130(2S Suppl): 396S-402S.
30. Sakai T, Ogura Y, Narita J, Suto T, Kimura D, Ainai S, Fujita H, Kamada M (2003) Simultaneous early adenocarcinoma and mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach associated with Helicobacter pylori infection. Gastric Cancer 6(3): 191-196.
31. Sgouras D, Maragkoudakis P, Petraki K, Martinez-Gonzalez B, Eriotou E, Michopoulos S, Kalantzopoulos G, Tsakalidou E, Mentis A (2004) In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota. Appl Environ Microbiol 70(1): 518-526.
32. Stingl K, Uhlemann Em EM, Deckers-Hebestreit G, Schmid R, Bakker EP, Altendorf K (2001) Prolonged survival and cytoplasmic pH homeostasis of Helicobacter pylori at pH 1. Infect Immun 69(2): 1178-1180.
33. Vandenplas Y (2000) Helicobacter pylori infection. World J Gastroenterol 6(1): 20-31.
34. Wang JH, Wang JB, Li Y, Jiao J, Zhang XY (2007) Study on the correlated bionomics of the Lactobacillus acidophilus with Hp antagonistic activity. Chin J Immunol 23(4): 300-305.
35. Wang JB, Qi WQ, Li B, Qin SY, Yu F, Ji SW (2011) Helicobacter pylori infection and extragastic diseases. Chin J Dig 31(5): 358-360.
36. Ward JM, Anver MR, Haines DC, Benveniste RE (1994) Chronic active hepatitis in mice caused by Helicobacter hepaticus. Am J Pathol 145(4): 959-968.
37. Yeung PS, Sanders ME, Kitts CL, Cano R, Tong PS (2002) Species-specific identification of commercial probiotic strains. J Dairy Sci 85(5): 1039-1051.